Targeted Drug Delivery Market, by Disease Type (Cardiovascular Diseases, Pulmonary Diseases, Infectious Diseases, Endocrine Diseases, and Oncological Disorders), by Application (First Order Targeting (Organ Compartmentalization), Second Order Targeting (Cellular Targeting), and Third Order Targeting (Intracellular Targeting), by End User (Hospitals, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Targeted drug delivery is the selective transport of drug to targeted tissues, organs, and cells through various drug carriers. Targeted drug delivery is designed to improve the pharmacological and therapeutic properties of conventional drugs and to overcome problems, such as limited solubility, drug aggregation, poor bio-distribution, and lack of selectivity, control drug release carrier, and reduce normal tissue damage. With the non-toxic and biodegradable characteristics, it can increase the retention of drug in the lesion site and the permeability, and improve the concentration of the drug in lesion site.
There are different types of drug delivery vehicles, such as polymeric micelles, liposomes, lipoprotein-based drug carriers, nanoparticle drug carriers, and dendrimers. An ideal drug delivery vehicle is nontoxic, biocompatible, biodegradable, and non-immunogenic and must avoid recognition by the host defense mechanism.
Market Dynamics
The increasing population of diabetes, rising research and development activities, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive the growth of the global targeted drug delivery market over the forecast period. For instance, in September 2021, Oncxerna Therapeutics Inc. a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its targeted oncology therapies, has announced new clinical and biomarker data from its bavituximab program in an electronic poster at the European Society of Medical Oncology (ESMO) congress 2021.
Moreover, the increasing cases of diabetes are also anticipated to augment the market growth over the forecast period. According to the International Diabetes Federation in 2021, approximately 537 million adults (20-79) are living with diabetes.
Key features of the study:
- This report provides an in-depth analysis of the global targeted drug delivery market, market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global targeted drug delivery market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include AbbVie Inc., Ablynx NV by Sanofi SA, Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca PLC, Boston Scientific Corporation, Becton, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC., Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Vectura Group PLC, Taiwan Liposome Company, Ltd., and 3M.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global targeted drug delivery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global targeted drug delivery market
- Global Targeted Drug Delivery Market, By Disease Type:
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
- Global Targeted Drug Delivery Market, By Application:
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- Global Targeted Drug Delivery Market, By End User:
- Hospitals
- Clinics
- Others
- Global Targeted Drug Delivery Market, By Region:
- North America
- By Disease Type
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
- By Application
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- By End User
- Hospitals
- Clinics
- Others
- By Country
- U.S.
- Canada
- Latin America
- By Disease Type
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
- By Application
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- By End User
- Hospitals
- Clinics
- Others
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Disease Type
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
- By Application
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- By End User
- Hospitals
- Clinics
- Others
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Disease Type
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
- By Application
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- By End User
- Hospitals
- Clinics
- Others
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Disease Type
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
- By Application
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- By End User
- Hospitals
- Clinics
- Others
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Disease Type
- Cardiovascular Diseases
- Pulmonary Diseases
- Infectious Diseases
- Endocrine Diseases
- Oncological Disorders
- By Application
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- By End User
- Hospitals
- Clinics
- Others
- By Country
- South Africa
- Central Africa
- North Africa
- Company Profiles
- AbbVie Inc.*
- Company Overview
- Material Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Ablynx NV by Sanofi SA
- Arrowhead Pharmaceuticals, Inc.
- Baxter International Inc.
- AstraZeneca PLC
- Boston Scientific Corporation
- Becton
- Depomed, Inc.
- Fraunhofer Gesellschaft Munchen
- Janssen Global Services, LLC
- Luye Pharma Group
- Pfizer Inc.
- Quark Pharmaceuticals Inc.
- Rexahn Pharmaceuticals Inc.
- Savara Inc.
- Roche Holding AG
- Suda Limited
- Vectura Group PLC
- Taiwan Liposome Company, Ltd.
- 3M
- “*” marked represents similar segmentation in other categories in the respective section.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Disease Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- PEST Analysis
- Regulatory Scenario
- Market Trends
- Key Highlights
- Mergers & Acquisitions
- 4. Global Targeted Drug Delivery Market – Impact of Coronavirus (COVID-19) Pandemic
- Economic Impact
- Impact on Clinical Trials
- Government Initiatives
- 5. Global Targeted Drug Delivery Market, By Disease Type, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Pulmonary Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Endocrine Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Oncological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 6. Global Targeted Drug Delivery Market, By Application, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- First Order Targeting (Organ Compartmentalization)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Second Order Targeting (Cellular Targeting)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Third Order Targeting (Intracellular Targeting)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 7. Global Targeted Drug Delivery Market, By End User, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 8. Global Targeted Drug Delivery Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018–2030
- North America
- Market Size and Forecast, By Disease Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Disease Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Disease Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Disease Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Disease Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Disease Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2017 – 2030, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- 9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- AbbVie Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ablynx NV by Sanofi SA
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Arrowhead Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Baxter International Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- AstraZeneca PLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Boston Scientific Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Becton
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Depomed, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Fraunhofer Gesellschaft Munchen
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Janssen Global Services, LLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Luye Pharma Group
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Quark Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Rexahn Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Savara Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Roche Holding AG
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Suda Limited
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vectura Group PLC
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Taiwan Liposome Company, Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- 3M
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- 10. Section
- References
- Research Methodology
- About us and Sales Contact
- *Browse 38 market data tables and 26 figures on "Targeted Drug Delivery Market” - Global forecast to 2030.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook